Ashish Jha writes that AI is eroding the barriers that kept biological weapons rare
STAT · Public essay
Read the source (opens in a new tab)- What happened
- In a STAT First Opinion essay, Ashish Jha, a former White House Covid-19 response coordinator and senior fellow at Harvard Kennedy School's Belfer Center, argued biological threats are outpacing defenses.
- Key points
- He writes that biological weapons were rare because the needed expertise was hard to combine, and "AI is closing those gaps" by connecting ideas across subfields.
- He cites two reports this year, from Harvard and RAND, concluding AI "could broaden the range of actors able to mount a large-scale biological attack," while also aiding state programs.
- He says broad restrictions would also slow new therapies, and calls instead for layered defense: overseen researcher access, pre-release testing for dangerous capabilities, and audited customer checks by DNA synthesis providers.
- He says slowing model development is "worth doing," but only as "a bridge to building biodefense," concluding "Defenses against this threat take years to build. We don't have years to spare."
- Evidence
- An argument by a public health official in a publication's opinion section, not new data. It draws on published reports, Anthropic's disclosed misuse cases and a Nature Communications experiment.
- Uncertain
- Jha writes that neither the Harvard nor the RAND report claims the most dangerous thresholds have been crossed, "though neither rules it out." He is co-founder and CEO of BioRadar, a biological threat detection company.